Moleculin Biotech, INC Form 4 insider transactions

Jonathan P. Foster, CFO of Moleculin Biotech, reports the vesting and subsequent disposal of restricted stock units to cover tax obligations.

Walter Klemp, CEO and President of Moleculin Biotech, reports the acquisition and disposal of common stock and restricted stock units.

Donald H Picker, Chief Science Officer of Moleculin Biotech, Inc., reports the vesting of restricted stock units and subsequent tax withholding.

Jonathan P. Foster, CFO of Moleculin Biotech, reports the vesting and subsequent sale of shares to cover tax obligations.

Walter Klemp, CEO and President of Moleculin Biotech, reports the vesting of restricted stock units and associated tax withholding.

Jonathan P. Foster, CFO of Moleculin Biotech, reported the acquisition and disposal of common stock and restricted stock units on June 16, 2024.

Walter Klemp, CEO and President of Moleculin Biotech, reports the vesting of restricted stock units and subsequent tax withholding.